Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Disease

Mexico says coronavirus now endemic, not pandemic

The Mexican government says COVID-19 has passed from a pandemic to an endemic stage in Mexico, meaning authorities will treat it as a seasonally recurring disease

The Independent UK

Daily aspirin to prevent heart disease and stroke no longer recommended for people 60 and older

This might be a tough pill to swallow.

Tribune News Service

Majority of Americans, including 3 out of 4 children, have had Covid-19, CDC finds

US has reached ‘inflection’ point in public health crisis as infections climb

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Disease-causing parasites can hitch a ride on plastics and potentially spread through the sea, new research suggests

Typically when people hear about plastic pollution, they might envision seabirds with bellies full of trash or sea turtles with plastic straws in their noses. However, plastic pollution poses another threat that’s invisible to the eye and has important consequences for both human and animal health.

The Conversation

COVID-19: Survey shows 30% of respondents who had taken third dose vaccine contracted disease during third wave in India

Questionnaire-based survey conducted by a group of Kochi-based doctors among 5,971 adults across the country to assess the community level experience of the pandemic

The Hindu

Valneva - Pfizer Post Encouraging Data From Lyme Disease Vaccine Candidate

Valneva SE (NASDAQ:VALN) and Pfizer Inc (NYSE:PFE) have reported Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15. In pediatric participants (5-17 years old) who received VLA15 in either the two-dose schedule (N=93) or three-dose schedule (N=97), VLA15 was found to be more immunogenic than in adults with both vaccination schedules tested. These…

Benzinga

Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia

The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to EDIT-301, an investigational, gene-edited medicine for the treatment of beta thalassemia from leading genome editing company, Editas Medicine, Inc. (NASDAQ: EDIT).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease

Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate PRX012 for the treatment of Alzheimer's disease.

Benzinga

Claim PIP for chronic pain and DWP could give you up to £156 each week

Successful PIP claimants could receive between £97.80 and £627.60 every four weeks.

Daily Record

'No link' found as global cases of mysterious hepatitis liver disease in children increases to 190

10 British children have required liver transplants as a result of the disease.

Wales Online

How Robert Langer, a pioneer in delivering mRNA into the body, failed repeatedly but kept going: 'They said I should give up, but I don't like to give up'

The mRNA vaccines developed against COVID-19 owe a lot to the work of Robert Langer, a pioneer in the delivery of mRNA. Langer, who is the Massachusetts Institute of Technology David H. Koch Institute Professor and director of the Langer Lab, helped lay the foundation for the underlying delivery mechanism…

The Conversation

Devastated dad's heart-breaking diagnosis after pain from 'trapped nerve' in foot

Chris Thurston was actually suffering from foot drop, which is an early signal of incurable Motor Neurone Disease

Wales Online

Adenovirus symptoms in full as parents warned of mystery liver disease in children

Children have been presenting with nasty symptoms of hepatitis thought to be caused by a type of adenovirus - here's what you need to know about the liver disease symptoms to look out for

Daily Mirror

Biotech firm ReViral acquired by Pfizer in £412m deal

ReViral was co-founded by former Durham University lecturer Professor Stuart Cockerill and has a North East research and development facility at Sedgfield's NETPark

Birmingham Post

Get all your
news in one place.

100's of premium titles.
One news app.

Glasgow Live

DWP PIP could be worth up to £627 a month if you have one of these 21 conditions

People with a disability or physical or mental health condition could be eligible for as much as £627 every four weeks in Personal Independence Payments from the Department for Work and Pensions

Daily Record

SNP candidate suggests opponents of independence 'more likely to have degenerative brain diseases'

Jim McHarg - who is standing in the Ardrossan ward - made the "puerile and offensive" claim on a social media.

Daily Record

Ebola outbreak confirmed as WHO sounds alarm after second person dies from disease

The World Health Organisation (WHO) has sounded the alarm after a second person has died from the deadly disease in the Democratic Republic of the Congo.

Bristol Post

Ebola outbreak: WHO issues warning as second patient dies from deadly disease

This is the 14th Ebola outbreak that the Democratic Republic of the Congo has seen since 1976, and follows another outbreak just four months ago

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Mayo Clinic Minute: Improved treatments for head and neck cancer

April is Sexually Transmitted Infections Awareness Month. About 70% of cancers in the oropharynx, which includes the tonsils, soft palate and base of the tongue, are linked to the HPV virus, according to the Centers for Disease Control and Prevention. So it's important to talk to your health care team…

Chicago Sun-Times

Life expectancy gap widens among Black and white Chicagoans during first year of pandemic; Latinos suffer steepest drop

COVID-19 deaths drove much of the change but wasn’t the leading factor for it. The deadly virus was second to heart disease deaths — which increased with other chronic diseases like diabetes.

Bangkok Post

Covid-19 not yet endemic

Thailand cannot yet declare Covid-19 as an endemic disease as the country is still at risk of a fresh wave being triggered, Dr Prasit Watanapa, dean of Mahidol University's Faculty of Medicine, warned on Monday.

Reason

If the CDC's Mask Mandate Is 'Necessary for the Public Health,' Why Didn't the DOJ Seek a Stay To Restore It?

The Biden administration's main priority seems to be leaving the agency's authority vague enough to allow future interventions.

Benzinga

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ:WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE:TEVA), AbbVie Inc's (NYSE:ABBV) Allergan unit, and Teva-owned Anda Inc created a "public nuisance" by flooding the city with prescription opioids and failing…

Newcastle Herald

Fatal pet disease resurfaces at Speers Point

A rare and potentially fatal disease affecting dogs has appeared in Lake Macquarie for the first time in decades.

Benzinga

Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial

The independent Data and Safety Monitoring Board (DSMB) for Ocugen Inc's (NASDAQ:OCGN) Phase 1/2 trial of OCU400 has recommended that the study proceeds with enrolling additional subjects. The recommendation follows the review of safety data based on dosing to date. OCU400 is the Company's flagship modifier gene therapy candidate for Retinitis Pigmentosa (RP)…

1 … 639 640 641 642

People

Kathryn Kimball Mizelle

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department for Work and Pensions

373 stories

PFE

348 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.